The role of myeloid-derived suppressor cells (MDSCs) in graft-versus-host disease (GVHD)

C Demosthenous, I Sakellari, V Douka… - Journal of clinical …, 2021 - mdpi.com
Background: Myeloid-derived suppressor cells (MDSCs) are implicated in the complex
interplay involving graft-versus-leukemia (GVL) effects and graft-versus-host disease …

British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017

KE Harman, D Brown, LS Exton… - British Journal of …, 2017 - academic.oup.com
British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris
2017 | British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement …

[HTML][HTML] Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

I Bojanic, N Worel, CP Pacini, G Stary… - Frontiers in …, 2023 - frontiersin.org
Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Extracorporeal photopheresis for graft‐vs‐host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group

M Nygaard, S Wichert, G Berlin… - European Journal of …, 2020 - Wiley Online Library
Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from …

Ø Bruserud, THA Tvedt, PQ Paulsen, AB Ahmed… - Cancer Immunology …, 2014 - Springer
Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and …

M Bartnik, A Sławińska-Brych, A Żurek… - Journal of …, 2017 - Elsevier
Abstract Ethnopharmacological relevance 8-methoxypsoralen (8-MOP) is a furanocoumarin
and an active compound of a traditional Egyptian medicinal plant Ammi majus L, whose …

The selective therapeutic apheresis procedures

AP Sanchez, R Cunard… - Journal of Clinical …, 2013 - Wiley Online Library
Selective apheresis procedures have been developed to target specific molecules,
antibodies, or cellular elements in a variety of diseases. The advantage of the selective …

[HTML][HTML] Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma

D Hannani - Frontiers in immunology, 2015 - frontiersin.org
Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …

Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD

N Rieber, I Wecker, D Neri, K Fuchs, I Schäfer… - Bone marrow …, 2014 - nature.com
Extracorporeal photopheresis (ECP) is beneficial in patients with T-cell-mediated disorders,
including GvHD, but the underlying immunological mechanisms are incompletely …

Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T‐cell lymphoma: a single center clinical experience with long‐term follow‐up data and a …

P Quaglino, R Knobler, MT Fierro… - International journal …, 2013 - Wiley Online Library
Extracorporeal photopheresis (ECP) is a therapeutic procedure in which leukapheresed
peripheral blood mononuclear cells are exposed to ultraviolet A in the presence of the …